ATX-S10(Na)-photodynamic therapy inhibits cytokine secretion and proliferation of lymphocytes.
Takahashi
Hidetoshi
H
Ishida-Yamamoto
Akemi
A
Nakajima
Susumu
S
Sakata
Isao
I
Iizuka
Hajime
H
D049109:Cell Proliferation / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D019169:Jurkat Cells; D007834:Lasers; D008213:Lymphocyte Activation / Q000187:drug effects*; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000494:pharmacology* / Q000528:radiation effects; D011166:Porphyrins / Q000494:pharmacology* / Q000528:radiation effects; D013601:T-Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
C117772:ATX S10Na(II); D016207:Cytokines; C508600:IL6 protein, human; D015850:Interleukin-6; D016209:Interleukin-8; D017319:Photosensitizing Agents; D011166:Porphyrins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma